Advancing the Role of Pharmacy in Tobacco Cessation

提升药房在戒烟中的作用

• 批准号: 10683740
• 负责人: KAREN S HUDMON
• 金额: $ 24.23万
• 依托单位: PURDUE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-09-18 至 2024-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10683740
• 关键词: Address; Arizona; Authorization documentation; Awareness; Bupropion; California; Colorado; Combination Drug Therapy; Communities; Continuing Education; Counseling; Development; E-learning; Education; Educational process of instructing; Ensure; Evaluation; Excision; FDA approved; Faculty; Feedback; Funding; Future; Goals; Grant; Health; Health Expenditures; Health Personnel; Health Professional; Hour; Human Resources; Idaho; Indiana; Individual; Kentucky; Laws; Licensing; Maine; Methodology; Methods; Minor; Morbidity - disease rate; New Mexico; Online Systems; Oregon; Participant; Patient Care; Patients; Persons; Pharmaceutical Preparations; Pharmacists; Pharmacy Schools; Pharmacy Students; Pharmacy facility; Phase; Population; Process; Program Development; Protocols documentation; Provider; Role; Schools; Series; Site; Smoke; Smoker; Speed; Statutes and Laws; Students; Surveys; Tobacco; Tobacco Use Cessation; Tobacco use; Trainers Training; Training; Training Programs; United States; United States Public Health Service; Work; authority; care outcomes; effective therapy; evidence base; experience; innovation; meetings; member; mortality; nicotine replacement; novel strategies; program dissemination; programs; quitline; response; skills; smoking cessation; theories; tobacco user; varenicline

Although most tobacco users would like to quit, the majority do not receive professional assistance, and fewer than 5% who try to quit on their own are successful. The most effective approach for quitting combines pharmacotherapy with counseling, yet few clinicians routinely address tobacco use in practice. In recent years, only minor advancements have been made toward increasing the proportion of patients who receive professional assistance or use FDA-approved cessation medications, and novel approaches are needed to disrupt the status quo. One largely untapped yet highly accessible population of providers is pharmacists. In 2004, New Mexico implemented the first protocol granting pharmacists authority to prescribe smoking cessation medications, and eight additional states recently have signed similar legislation into law (with another 14 states in the process). While the passage of legislation is an essential first step, the second step – preparing the profession to act on these new prescriptive authorities – is equally important. The primary objective of this R25 application is to provide assistance to states attempting to advance pharmacy’s role in tobacco cessation. Through partnerships with key organizations, we will develop and disseminate training programs for all members of the pharmacy profession: pharmacists, pharmacy technicians, and pharmacist preceptors who host experiential training sites for pharmacy students. Program development and dissemination will be grounded in theory, building upon strong methodology established in our team’s prior work. More broadly, we will build bridges between the pharmacy profession, State Departments of Health, and tobacco quitlines, thereby providing patients with increased access to evidence-based methods for quitting. The specific aims of this R25 application are to: AIM 1. Develop a suite of live and enduring web-based tobacco cessation training programs for (a) pharmacy personnel, including pharmacists and technicians, and (b) pharmacist preceptors who host experiential training sites for pharmacy students. AIM 2. In a pilot Phase I (Years 01/02), conduct a series of 5 live training programs for Indiana pharmacists and launch web-based trainings for Indiana pharmacists and technicians. AIM 3. Revise materials, as appropriate, based on feedback from Phase I participants prior to a full-launch Phase II (Years 02–05), providing live and web-based trainings in states where pharmacists can prescribe smoking cessation medications. Overall, an estimated 5,680 pharmacists and 1,000 technicians will be trained. AIM 4. Apply a mixed methods evaluation approach to estimate the reach and impact of the training programs. This proposed educational initiative is both timely and needed—importantly, it capitalizes on heightened awareness due to recent legislative advances, and it builds upon our team’s decades of experience in training pharmacists, technicians, and students to assist their patients with the cessation of tobacco use.

尽管大多数烟草用户都想退出，但大多数人没有获得专业帮助，更少 超过5％的人成功辞职。戒烟的最有效方法 与咨询有关的药物治疗，但很少有临床医生通常在实践中解决烟草的使用。近年来，仅 为增加接受专业的患者比例而取得了较小的进步 援助或使用FDA批准的戒烟药物，需要采取新颖的方法来破坏身份报价。 药剂师是一位尚未开发但高度可访问的提供者人口。 2004年，新墨西哥州 实施了第一个授予药剂师授权的方案，以准备戒烟药物，并 最近，其他八个州已将类似的立法签署为法律（此过程中还有14个州）。 虽然立法的通过是必不可少的第一步，但第二步 - 准备行动以采取行动 这些新的规范当局 - 同样重要。 该R25申请的主要目的是为试图促进的州提供帮助 药房在烟草戒烟中的作用。通过与关键组织的合作伙伴关系，我们将发展并 为药学专业所有成员传播培训计划：药剂师，药房技术， 和药剂师的主持人，他们为药房学生提供专家培训网站。计划开发和 理论上将基于我们团队先前的工作中建立的强大方法基础的传播基础。 更广泛地说，我们将在药房专业，州卫生部和烟草之间建造桥梁 戒烟线，从而为患者提供了增加循证戒烟方法的机会。 该R25应用程序的具体目的是： 目标1。为（a）药房开发一套现场和持久的基于网络的烟草戒烟培训计划 人员，包括药剂师和技术人员，以及（b）主持专家的药剂师受体 药房学生的培训网站。 AIM 2。在第一阶段（01/02年）中，为印第安纳州药剂师和 为印第安纳州的药剂师和技术人员启动基于网络的培训。 AIM 3。根据I阶段参与者的反馈在全面发布阶段之前根据I阶段参与者的反馈进行修改 II（02-05年），在药剂师可以开具吸烟的州提供实时和基于网络的培训 停止药物。总体而言，估计有5,680名药剂师和1,000名技术人员将接受培训。 目标4。采用混合方法评估方法来估计培训计划的影响力和影响。 这项提出的教育倡议既及时又需要 由于最近的立法进步而引起的意识，这是基于我们团队在培训方面的数十年经验 药剂师，技术人员和学生以停止使用烟草的使用。

项目成果

Pharmacist-Led Implementation of Brief Tobacco Cessation Interventions during Mobile Health Access Events.

• DOI: 10.3390/pharmacy11020072
• 发表时间: 2023-04-07
• 期刊: Pharmacy (Basel, Switzerland)
• 作者: Hudmon KS;Czarnik JS;Lahey AM;Crowe SJ;Conklin M;Corelli RL;Gonzalvo JD;Hilts KE
• 通讯作者: Hilts KE